REGN News

Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)

REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Regeneron Pharmaceuticals, Inc. to Contact the Firm Today!

September 14, 2026 Deadline Approaching: Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN) – Contact Levi & Korsinsky

Pomerantz LLP Reminds Shareholders: Securities Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. – REGN

Class Action Lawsuit Reminder from Pomerantz LLP for Investors of Regeneron Pharmaceuticals, Inc. – REGN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT

Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. (REGN) Investors - Lead Plaintiff Deadline on September 14, 2026

Pomerantz LLP Reminds Shareholders with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit – REGN

Securities Lawsuit Alert: Regeneron Pharmaceuticals, Inc. (REGN) - Contact Levi & Korsinsky Before September 14, 2026

Robbins LLP Urges REGN Investors to Contact the Firm Before the September 14, 2026, Lead Plaintiff Deadline in the Class Action Against Regeneron Pharmaceuticals, Inc.